Target Identification Services ​

Accelerate results, uncover novel disease features, and gain deeper insights into complex cell behavior.

Biotech CRO in Space​

  • Feasibility assessment​

  • Assay adaptation​

  • Optimization & Automation​

  • Preparation & Launch​

  • HTS execution​

Biotech CRO in Space​

  • Feasibility assessment​

    We focus on the biological question, identify the best model and test if compatibility with space operations​

  • Assay adaptation​

    We adapt the assay protocol to suit our system requirements​.

  • Optimization & Automation​

    We optimize experimental conditions to get maximum value from the mission​.

  • Preparation & Launch​

    We book the mission, perform safety review, and prepare all materials for launch​

Case Study​

Disease modeling to clinical trials in 3 missions​

Read how previous work in the National Lab of the International Space Station let to sped up drug development, and how a very promising drug candidate was found for aggressive breast cancer​.

News & Insights

Featured
Exobiosphere secures LuxIMPULSE contract
Exobiosphere secures LuxIMPULSE contract

Exobiosphere Secures LuxIMPULSE Contract to Advance Space-Based Drug Discovery

Exobiosphere has been awarded a LuxIMPULSE contract funded by the Government of Luxembourg, with technical oversight from the European Space Agency and implementation with the Luxembourg Space Agency. This support will drive the development of the Orbital High-Throughput Screener, a space-based drug discovery platform designed to expand research capabilities in oncology, regenerative medicine, and immunotherapy.

Read More →
Exobiosphere joins EYnovation™ to accelerate Space-based Biotech
Exobiosphere joins EYnovation™ to accelerate Space-based Biotech

Exobiosphere has been selected to take part in the EYnovation™ program, an initiative by Ernst & Young (EY) designed to support high-potential startups and scaleups through strategic business advisory, access to an extensive network, and tailored growth acceleration services. This partnership marks another key milestone in the company’s mission to redefine drug discovery through space-based biotechnology.

Read More →
Dr. Bruno Santos joins Exobiosphere as the Director of R&D
Dr. Bruno Santos joins Exobiosphere as the Director of R&D

LUXEMBOURG – Exobiosphere is at the forefront of biotechnology innovation, leveraging the unique conditions of space to revolutionize drug discovery. This vision takes another step forward with the addition of Dr. Bruno Santos as the Director of Research & Development.

Read More →

Contact Us